Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. Moriwaki · SciRah

Researcher profile · Semantic Scholar

K. Moriwaki

Share profile

K. Moriwaki — researcher profile on SciRah

h-index: 11
Works: 79
Citations: 523

Most-cited papers

Development of an Official Guideline for the Economic Evaluation of Drugs/Medical Devices in Japan.
T. Shiroiwa, T. Fukuda, S. Ikeda, T. Takura +1 more
2017Value in Health138 citations Open access
Semantic Scholar
Cost-effectiveness of cinacalcet hydrochloride for hemodialysis patients with severe secondary hyperparathyroidism in Japan.
H. Komaba, K. Moriwaki, S. Goto, S. Yamada +4 more
2012American Journal of Kidney Diseases51 citations
Semantic Scholar
Economic evaluation of osteoporosis liaison service for secondary fracture prevention in postmenopausal osteoporosis patients with previous hip fracture in Japan
K. Moriwaki, S. Noto
2017Osteoporosis International41 citations
Semantic Scholar
Proton beam therapy for children and adolescents and young adults (AYAs): JASTRO and JSPHO Guidelines.
M. Mizumoto, H. Fuji, M. Miyachi, T. Soejima +32 more
2021Cancer Treatment Reviews39 citations Open access
Semantic Scholar
Cost‐effectiveness of alendronate for the treatment of osteopenic postmenopausal women in Japan
K. Moriwaki, H. Komaba, S. Noto, S. Yanagisawa +5 more
2013Journal of Bone and Mineral Research28 citations
Semantic Scholar
Clinical efficacy and cost-effectiveness of lanthanum carbonate as second-line therapy in hemodialysis patients in Japan.
S. Goto, H. Komaba, K. Moriwaki, A. Fujimori +11 more
2011American Society of Nephrology. Clinical Journal28 citations Open access
Semantic Scholar
Cost-effectiveness analysis of oseltamivir for influenza treatment considering the virus emerging resistant to the drug in Japan.
H. Nagase, K. Moriwaki, M. Kamae, S. Yanagisawa +1 more
2009Value in Health24 citations Open access
Semantic Scholar
Cost-effectiveness of a hybrid emergency room system for severe trauma: a health technology assessment from the perspective of the third-party payer in Japan
T. Kinoshita, K. Moriwaki, N. Hanaki, T. Kitamura +4 more
2020World Journal of Emergency Surgery21 citations Open access
Semantic Scholar
Cost-effectiveness analysis of once-yearly injection of zoledronic acid for the treatment of osteoporosis in Japan
K. Moriwaki, M. Mouri, H. Hagino
2016Osteoporosis International21 citations Open access
Semantic Scholar
A model-based cost-effectiveness analysis of osteoporosis screening and treatment strategy for postmenopausal Japanese women
M. Yoshimura, K. Moriwaki, S. Noto, T. Takiguchi
2017Osteoporosis International15 citations
Semantic Scholar
Cost-effectiveness analysis of universal screening for biliary atresia in Japan.
E. Hoshino, K. Moriwaki, Kosuke Morimoto, K. Sakai +5 more
2022Jornal de Pediatria11 citations Open access
Semantic Scholar
Cost-effectiveness of implementing guidelines for the treatment of glucocorticoid-induced osteoporosis in Japan
K. Moriwaki, Haruhisa Fukuda
2019Osteoporosis International10 citations
Semantic Scholar
Present developments in reaching an international consensus for a model-based approach to particle beam therapy
A. Prayongrat, K. Umegaki, A. van der Schaaf, A. Koong +14 more
2018Journal of Radiation Research10 citations Open access
Semantic Scholar
Cost effectiveness of the occupation-based approach for subacute stroke patients: result of a randomized controlled trial
H. Nagayama, K. Tomori, Kanta Ohno, Kayoko Takahashi +4 more
2017Topics in Stroke Rehabilitation10 citations
Semantic Scholar
Cost-Effectiveness of Nab-Paclitaxel and Gemcitabine Versus Gemcitabine Monotherapy for Patients with Unresectable Metastatic Pancreatic Cancer in Japan.
Kosuke Morimoto, K. Moriwaki, Takako Kaneyasu, Hitomi Nakayama +1 more
2021Value in Health Regional Issues9 citations Open access
Semantic Scholar
Towards Cost‐effective Strategies for Treatment of Chronic Kidney Disease‐Mineral and Bone Disorder in Japan
H. Komaba, K. Moriwaki, I. Kamae, M. Fukagawa
2009Therapeutic apheresis and dialysis8 citations Open access
Semantic Scholar
Direct health care cost of treatment and medication of biliary atresia patients using the National Database of Health Insurance Claims and Specific Health Checkups
E. Hoshino, Keiko Konomura, M. Obatake, K. Moriwaki +3 more
2022Pediatric surgery international (Print)7 citations Open access
Semantic Scholar
Economic Evaluation of First-Line Pertuzumab Therapy in Patients with HER2-Positive Metastatic Breast Cancer in Japan
K. Moriwaki, S. Uechi, T. Fujiwara, Y. Hagino +1 more
2021PharmacoEconomics - Open7 citations Open access
Semantic Scholar
Cost-effectiveness analysis for HbA1c test intervals to screen patients with type 2 diabetes based on risk stratification
S. Ohde, K. Moriwaki, O. Takahashi
2019BMC Endocrine Disorders7 citations Open access
Semantic Scholar
Cost-Effectiveness Analysis of Safety-Engineered Devices
H. Fukuda, K. Moriwaki
2016Infection Control & Hospital Epidemiology7 citations
Semantic Scholar
A Warning Index Used in Prescreening for Alzheimer's Disease, Based on Self-Reported Cognitive Deficits and Vascular Risk Factors for Dementia in Elderly Patients with Type 2 Diabetes
Toshioki Matsuzawa, T. Takata, K. Yokono, H. Ueda +4 more
2012International Journal of Alzheimer's Disease7 citations Open access
Semantic Scholar
Absolute lymphocyte count at the end of induction therapy is a prognostic factor in childhood acute lymphoblastic leukemia
Satoshi Hirase, Daiichiro Hasegawa, H. Takahashi, K. Moriwaki +13 more
2015International journal of hematology6 citations
Semantic Scholar
The relationship between preference-based health-related quality of life and lifestyle behavior: a cross-sectional study on a community sample of adults who had undergone a health check-up
S. Noto, O. Takahashi, Takeshi Kimura, K. Moriwaki +1 more
2020Health and Quality of Life Outcomes5 citations Open access
Semantic Scholar
Differences in healthcare expenditure estimates according to statistical approach: A nationwide claims database study on patients with hepatocellular carcinoma
H. Fukuda, Daisuke Sato, K. Moriwaki, H. Ishida
2020PLoS ONE4 citations Open access
Semantic Scholar
Factors influencing the prescribed dose of opioid analgesics in cancer patients.
M. Hashimoto, Kazuki Aogaki, Chikako Numata, K. Moriwaki +4 more
2020Journal of Opioid Management2 citations
Semantic Scholar
[Epidemiology of bone and joint disease - the present and future - . Health economics of osteoporosis and osteoporotic fractures].
K. Moriwaki
2014Clinical calcium2 citations
Semantic Scholar
PCV73 CONSTRUCT VALIDITY OF HEALTH UTILITIES INDEX (HUI) JAPANESE VERSION: CROSS-SECTIONAL STUDY FOR STROKE IN JAPAN
S. Noto, Takamoto Uemura, R. Izumi, K. Moriwaki
20112 citations Open access
Semantic Scholar
EE361 Preliminary Cost-Effectiveness Analysis of Proton Beam Therapy in Patients with Hepatocellular Carcinoma in Japan
K. Moriwaki, N. Katoh, H. Hayashi, T. Miyakoshi +7 more
2022Value in Health1 citations Open access
Semantic Scholar
Development of An Economic Model to Assess the Cost-Effectiveness of Proton Beam Therapy in Patients with Hepatocellular Carcinoma in Japan
Y. Hagino, K. Moriwaki
2018Value in Health1 citations Open access
Semantic Scholar
Validation of Fracture Risk Model In Japanese Women Compared With Frax.
K. Moriwaki, S. Noto
2015Value in Health1 citations Open access
Semantic Scholar
PMC1 CORRECTING AN UNDERESTIMATE OF INCREMENTAL COST EFFECTIVENESS RATIO CONSIDERING STATISTICAL ERRORS AND PROBABILITY OF TRUTH
I. Kamae, K. Moriwaki, M. Kamae
20091 citations Open access
Semantic Scholar
EE500 Cost-Effectiveness Analysis of Cemiplimab As Second-Line Therapy for Recurrent Cervical Cancer in Japan
Y. T. Shibata Maeda, W. Chen, K. Morimoto, K. Moriwaki +1 more
2023Value in Health0 citations
Semantic Scholar
EE380 Cost-Effectiveness Analysis of Erlotinib Plus Bevacizumab As First-Line Therapy for Advanced EGFR Mutation-Positive Non-Squamous Non-Small Cell Lung Cancer in Japan
S. Yoshioka, W. Chen, T. Maeda, K. Morimoto +2 more
2023Value in Health0 citations
Semantic Scholar
EE42 Economic Evaluation of Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma in Japan
T. Tsuyuki, K. Morimoto, T. Maeda, W. Chen +2 more
2023Value in Health0 citations
Semantic Scholar
EE498 Economic Evaluation of Nanoparticle Albumin-Bound paclitaxel for Previously Treated Advanced NSCLC in Japan
Y. Fukui, W. Chen, T. Maeda, K. Morimoto +2 more
2023Value in Health0 citations
Semantic Scholar
EE164 Cost-Effectiveness of Nivolumab Plus Ipilimumab in Gastro-Oesophageal Cancer in Japan
T. Fukuda, K. Morimoto, T. Maeda, W. Chen +2 more
2023Value in Health0 citations
Semantic Scholar
EE260 Cost-Effectiveness Analysis of Sacituzumab Govitecan As Second-Line Treatment for Metastatic Triple-Negative Breast Cancer in Japan
M. Yamaguchi, T. Maeda, K. Morimoto, W. Chen +2 more
2023Value in Health0 citations
Semantic Scholar
POSC162 Cost Effectiveness Analysis of Nivolumab Plus Ipilimumab Therapy in Patients with Advanced Non-Small Cell Lung Cancer in Japan
X. Mo, K. Moriwaki, K. Morimoto, K. Shimozuma
2022Value in Health0 citations Open access
Semantic Scholar
HTA7 Cost-Effectiveness Analysis of Nivolumab Plus Chemotherapy Vs Chemotherapy in Patients with Advanced Gastric Cancer in Japan
K. Morimoto, K. Moriwaki, K. Shimozuma, T. Nakayama
2022Value in Health0 citations Open access
Semantic Scholar
POSA82 Cost-Effectiveness of Preventive Intervention for Prediabetes in Japan
H. Nakayama, K. Moriwaki, T. Kaneyasu, K. Morimoto +1 more
2022Value in Health0 citations Open access
Semantic Scholar
POSC280 Economic Evaluation of Nivolumab Plus Ipilimumab in Advanced Renal-Cell Carcinoma in Japan
T. Maeda, K. Morimoto, X. Mo, K. Moriwaki +1 more
2022Value in Health0 citations Open access
Semantic Scholar
Cost-Effectiveness of Osteoporosis Treatment
K. Moriwaki
2021Osteoporotic Fracture and Systemic Skeletal Disorders0 citations
Semantic Scholar
Cost-effectiveness analysis for HbA1c test intervals to screen patients with type 2 diabetes based on risk strati cation
S. Ohde, K. Moriwaki, Ritsumeikan Daigaku, O. Takahashi +1 more
20200 citations
Semantic Scholar
PDB42 COST-EFFECTIVENESS ANALYSIS FOR HBA1C TEST INTERVALS IN PATIENTS ON TREATMENT FOR STABLE TYPE 2 DIABETES
S. Ohde, K. Moriwaki, O. Takahashi
2019Value in Health0 citations Open access
Semantic Scholar
PCN110 PRELIMINARY ANALYSIS OF THE COST-EFFECTIVENESS OF NECITUMUMAB AS FIRST LINE THERAPY IN PATIENTS WITH STAGE IV SQUAMOUS NON SMALL CELL LUNG CANCER IN JAPAN
Y. Nishiuchi, M. Ueda, Y. Hirota, K. Moriwaki
2019Value in Health0 citations Open access
Semantic Scholar
PCN99 MODEL-BASED COST-EFFECTIVENESS ANALYSIS OF TRABECTEDIN IN THE TREATMENT OF METASTATIC SOFT TISSUE SARCOMA IN JAPAN
M. Ueda, Y. Hirota, Y. Nishiuchi, K. Moriwaki
2019Value in Health0 citations Open access
Semantic Scholar
PCN100 ECONOMIC EVALUATION OF FOLFIRINOX VERSUS GEMCITABINE IN THE TREATMENT OF METASTATIC PANCREATIC CANCER IN JAPAN
Y. Hirota, Y. Nishiuchi, M. Ueda, K. Moriwaki
2019Value in Health0 citations Open access
Semantic Scholar
Preliminary Analysis of the Cost-Effectiveness of Pertuzmab in Patients with Her2-Positive Breast Cancer in Japan
S. Uechi, K. Moriwaki
2018Value in Health0 citations Open access
Semantic Scholar
Preference-Based Health-Related Quality Of Life For Heart Disease Patients In Japan
S. Noto, T. Fukuda, S. Saito, K. Shimozuma +6 more
2018Value in Health0 citations Open access
Semantic Scholar
Estimation of Cost Parameters Using Claims Database for use in Cost-Effectiveness Analysis of Lung Cancer Treatment in Japan
T. Fujiwara, K. Moriwaki
2018Value in Health0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

K. Shimozuma×15
Invite
K. Shimozuma — researcher profile on SciRah
I. Kamae×6
Invite
I. Kamae — researcher profile on SciRah
W. Chen×6
Invite
W. Chen — researcher profile on SciRah
S. Noto×5
Invite
S. Noto — researcher profile on SciRah

×5

Invite

K. Morimoto — researcher profile on SciRah

Invite

T. Maeda — researcher profile on SciRah

Invite

H. Komaba — researcher profile on SciRah

Invite

M. Fukagawa — researcher profile on SciRah

O. Takahashi×4

Invite

O. Takahashi — researcher profile on SciRah

Invite

T. Fukuda — researcher profile on SciRah

Invite

S. Ohde — researcher profile on SciRah

Y. Nishiuchi×3

Invite

Y. Nishiuchi — researcher profile on SciRah